Cargando…
Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update
While guidelines for management of heart failure with reduced ejection fraction (HFrEF) are consensual and have led to improved survival, treatment options for heart failure with preserved ejection fraction (HFpEF) remain limited and aim primarily for symptom relief and improvement of quality of lif...
Autores principales: | Vaz-Salvador, Pedro, Adão, Rui, Vasconcelos, Inês, Leite-Moreira, Adelino F., Brás-Silva, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801287/ https://www.ncbi.nlm.nih.gov/pubmed/35098432 http://dx.doi.org/10.1007/s10557-021-07306-8 |
Ejemplares similares
-
Unveiling Human Proteome Signatures of Heart Failure with Preserved Ejection Fraction
por: Sebastião, Maria J., et al.
Publicado: (2022) -
Thyroid hormones and modulation of diastolic function: a promising
target for heart failure with preserved ejection fraction
por: Neves, João Sérgio, et al.
Publicado: (2020) -
Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013) -
Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012) -
Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction
por: Inácio, José M., et al.
Publicado: (2023)